Patents Assigned to Nautilus Biotech
  • Method for determining the titer of biological agents in living target cells
    Patent number: 7349812
    Abstract: Method for determining the titer (concentration) of biological agents, such as viral vectors for gene transfer, in real time, in living target cells and uses thereof in the field of gene therapy and diagnosis.
    Type: Grant
    Filed: April 28, 2006
    Date of Patent: March 25, 2008
    Assignee: Nautilus Biotech
    Inventor: Manuel Vega
  • Method for determining the titer of biological agents in living target cells
    Publication number: 20060195268
    Abstract: Method for determining the titer (concentration) of biological agents, such as viral vectors for gene transfer, in real time, in living target cells and uses thereof in the field of gene therapy and diagnosis.
    Type: Application
    Filed: April 28, 2006
    Publication date: August 31, 2006
    Applicant: NAUTILUS BIOTECH
    Inventor: Manuel Vega
  • Mutant recombinant adeno-associated viruses
    Publication number: 20030129203
    Abstract: Processes and systems for the high throughput directed evolution of peptides and proteins, particularly those that act in complex biological settings, are provided. The proteins and peptides include, but are not limited to, intracellular proteins, messenger/signaling/hormone proteins and viral proteins. Also provided is a rational method for generating protein variants and also a method for titering viruses.
    Type: Application
    Filed: December 17, 2001
    Publication date: July 10, 2003
    Applicant: Nautilus Biotech S.A.
    Inventors: Manuel Vega, Lila Drittanti, Marjorie Flaux